Albendazole
Back to searchMolecule Structure
Scientific Name
Albendazole
Description of the Drug
Albendazole is a benzimidazole anthelmintic used to treat parenchymal neurocysticercosis and other helminth infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00518
http://www.drugbank.ca/drugs/DB00518
Brand Name(s)
Albenza, Eskazole, Valbazen, Zental, Zentel
Company Owner(s)
Cipla Ltd, Msn Laboratories Private Ltd, Actavis Elizabeth Llc, Amedra Pharmaceuticals Llc, Dr Reddys Laboratories Ltd, Edenbridge Pharmaceuticals Llc, Strides Pharma Global Pte Ltd, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2364705 |
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2364704 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL44682 | ||
| PharmGKB | PA164746058 | ||
| Human Metabolome Database | HMDB0014659 | ||
| DrugBank | DB00518 | ||
| PubChem: Thomson Pharma | 14823901 | 16704067 | |
| PubChem | 2082 | ||
| Mcule | MCULE-5872469561 | ||
| NMRShiftDB | 20207369 | ||
| LINCS | LSM-3782 | ||
| Nikkaji | J11.391C | ||
| BindingDB | 50241293 | ||
| EPA CompTox Dashboard | DTXSID0022563 | ||
| DrugCentral | 103 | ||
| Brenda | 3447 | 143835 | |
| Rhea | 16664 | ||
| ChemicalBook | CB0241320 | ||
| rxnorm | VALBAZEN | ALBENZA | ALBENDAZOLE |
| PubChem: Drugs of the Future | 12014008 | ||
| KEGG Ligand | C01779 | ||
| ChEBI | 16664 | ||
| ZINC | ZINC000017146904 |
